Strides Pharma Science informs about press release

14 Nov 2022 Evaluate

Strides Pharma Science has informed that it attached Press Release issued by the Company titled: ‘Stelis receives a positive recommendation from European Medicines Agency (EMA) granting market authorization for KaulivTM, a recombinant human teriparatide biosimilar to treat osteoporosis’

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

790.00 -6.20 (-0.78%)
27-Jan-2026 12:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1635.00
Dr. Reddys Lab 1242.60
Cipla 1308.45
Zydus Lifesciences 891.95
Lupin 2143.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×